PURE Bioscience, Inc.
PURE
Rank in Stocks
#29261
PURE Bioscience, Inc. develops and commercializes antimicrobial products that... PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The companyโs technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a ready-to-use hard surface disinfectant and food contact surface sanitizer and disinfectant; PURE Control, eliminates pathogens in produce, such as salmonella, e. coli, and listeria; PURE Multi-Purpose Hi-Foam Floor Cleaner Concentrate, a cleaning product for stainless steel, floors, walls, and painted areas; PURE Multi-Purpose Floor Cleaner, for sanitation in food processing plants, commercial kitchens, healthcare facilities, schools, and hospitality settings; and SILVERION, a SDC-based antimicrobial formulation for use as a raw material ingredient in the manufacturing of personal care products. The company serves food processing, food service and hospitality, healthcare, facility care, transportation, and personal care industries. It sells its products through end-use customers and third-party distributors. The company was incorporated in 1992 and is based in El Cajon, California.
Share Price
$0.065
Last synced: 2026-11-09
Market Cap
$8.45M
Change (1 day)
8.33%
Change (1 year)
23.79%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade PURE Bioscience, Inc. (PURE)
Category
Basic Materials
EPS for PURE Bioscience, Inc. (PURE)
EPS as of July 2026 TTM: $-0.02
According to PURE Bioscience, Inc.'s latest financial reports, its current EPS (TTM) is $-0.02. At the end of 2025 the company had an EPS of $-0.02, an increase over its 2024 EPS of $-0.03.
EPS history for PURE Bioscience, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.02 | 7.00% |
| 2025 | $-0.02 | -28.43% |
| 2024 | $-0.03 | -16.01% |
| 2023 | $-0.04 | -9.64% |
| 2022 | $-0.04 | 48.12% |
| 2021 | $-0.03 | 26,500.00% |
| 2020 | 0.00 | -99.89% |
| 2019 | $-0.09 | -18.18% |
| 2018 | $-0.11 | 10.00% |
| 2017 | $-0.10 | -73.68% |
| 2016 | $-0.38 | 100.00% |
| 2015 | $-0.19 | -62.75% |
| 2014 | $-0.51 | -35.44% |
| 2013 | $-0.79 | -50.00% |
| 2012 | $-1.58 | -11.73% |
| 2011 | $-1.79 | 14.01% |
| 2010 | $-1.57 | -15.14% |
| 2009 | $-1.85 | -2.63% |
| 2008 | $-1.90 | 25.00% |
| 2007 | $-1.52 | 2.01% |
| 2006 | $-1.49 | 61.96% |
| 2005 | $-0.92 | -40.65% |
| 2004 | $-1.55 | -45.80% |
| 2003 | $-2.86 | 0.35% |
| 2002 | $-2.85 | 27.23% |
| 2001 | $-2.24 | -25.58% |
| 2000 | $-3.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $0.19 | -994.39% |
TW
|
|
| $1.72 | -8,142.99% |
JP
|
|
| $7.42 | -34,753.27% |
DE
|
|
| $-1.82 | 8,403.27% |
SA
|
|
| $0.91 | -4,362.15% |
CN
|
Questions about PURE Bioscience, Inc.'s earnings per share (EPS)
What is PURE Bioscience, Inc.'s earnings per share (EPS)?
PURE Bioscience, Inc.'s earnings per share (EPS) over the last twelve months is $-0.02, as of Jul 2026.
What was PURE Bioscience, Inc.'s earnings per share (EPS) in 2025?
In 2025, PURE Bioscience, Inc.'s earnings per share (EPS) was $-0.02, compared with $-0.03 in 2024.
How has PURE Bioscience, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, PURE Bioscience, Inc.'s earnings per share (EPS) was highest in 2020 (0.00) and lowest in 2023 ($-0.04).
How does PURE Bioscience, Inc.'s earnings per share (EPS) compare with similar companies?
PURE Bioscience, Inc.'s earnings per share (EPS) ($-0.02) is higher than that of 1 of the 5 similar companies listed above. The highest among them is BASF Se, with $7.42.